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We thank Dr. Fujita [1] for the constructive and
insightful comments about our recent report [2] and
appreciate the opportunity to respond to the questions
raised regarding: (1) the units used to express endotoxin
concentrations detected in blood; and (2) the interpreta-
tion of our ﬁndings about the potential role of endotoxin
in the hepatic microvascular responses to experimental
sepsis.
We regret the confusion that resulted from expressing
endotoxin concentrations in terms of both EU/ml and
pg/ml. Although we did not measure endotoxin activity
per se, the concentrations of endotoxin in plasma were
analyzed using a chromagenic limulus test and were esti-
mated based on standards constructed with endotoxin
serotype 055:B5. This serotype has an approximate
activity of 1 EU = 100 pg/ml, based on the manufac-
turer’s suggestions. Thus, our data can easily be con-
verted by simply multiplying the EU/ml values
provided in Table 2 by a factor of 100. However, since
endotoxin was undetectable following cecal ligation
and puncture (CLP), this conversion would not aﬀect
the overall outcome of the study.
Finally, we agree that rapid clearance of endotoxin
may account for lowered endotoxin levels in the circula-
tion of mice following CLP. Unlike the experiments
wherein only one dose of endotoxin was injected, CLP
likely induces the sustained release of endotoxin. As a
result, large amounts of endotoxin should have been
detected at any time point throughout the 6-h exposure,
especially in the portal blood draining the gut. The ab-
sence of detectable endotoxin in blood does not, on its
own, justify the conclusion that ‘‘our ﬁndings do not
support a major role for LPS in the hepatic microvascu-
lar disturbances associated with polymicrobial sepsis”.
This conclusion was based on a collective body ofevidence that included the absence of enhanced mRNA
expression for TLR-4 or the adaptor molecule MD-2 in
the livers of septic mice, as well as our observation that
the hepatic microcirculation of endotoxin-sensitive and -
insensitive (TLR-4 deﬁcient) mice responded in a nearly
identical fashion to CLP, while the TLR-4 mutants were
protected against exogenous endotoxin. We believe that
these observations following CLP, coupled with the ab-
sence of detectable endotoxin in blood, warrant the con-
clusion drawn in our report. Additional work is needed
to further address the importance of endotoxin and
products from Gram-positive bacteria in liver
pathology.
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